142 related articles for article (PubMed ID: 26494389)
1. Primary Hyperparathyroidism in MEN2 Syndromes.
Alevizaki M; Saltiki K
Recent Results Cancer Res; 2015; 204():179-86. PubMed ID: 26494389
[TBL] [Abstract][Full Text] [Related]
2. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
3. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2A in a 5-year-old child.
Magalhães PK; Antonini SR; de Paula FJ; de Freitas LC; Maciel LM
Thyroid; 2011 May; 21(5):547-50. PubMed ID: 21449769
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 2.
Lodish M
Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia, the old and the new: a mini review.
Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
[TBL] [Abstract][Full Text] [Related]
8. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
9. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
10. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
11. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
Marx SJ; Simonds WF; Agarwal SK; Burns AL; Weinstein LS; Cochran C; Skarulis MC; Spiegel AM; Libutti SK; Alexander HR; Chen CC; Chang R; Chandrasekharappa SC; Collins FS
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
[TBL] [Abstract][Full Text] [Related]
13. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).
Jimenez C; Gagel RF
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 2: 2007 update.
Raue F; Frank-Raue K
Horm Res; 2007; 68 Suppl 5():101-4. PubMed ID: 18174721
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 2.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
[TBL] [Abstract][Full Text] [Related]
16. Pediatric head and neck manifestations associated with multiple endocrine neoplasia syndromes.
Jellins T; Hill M; Prager JD; Francom CR; Chan CM; Schneider KW; Sharma A; Herrmann BW
Int J Pediatr Otorhinolaryngol; 2023 Oct; 173():111703. PubMed ID: 37604101
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.
Margraf RL; Crockett DK; Krautscheid PM; Seamons R; Calderon FR; Wittwer CT; Mao R
Hum Mutat; 2009 Apr; 30(4):548-56. PubMed ID: 19177457
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review.
Sovrea AS; Dronca E; Galatâr M; Radian S; Vornicescu C; Georgescu C
Rom J Morphol Embryol; 2014; 55(2):389-400. PubMed ID: 24969991
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
[TBL] [Abstract][Full Text] [Related]
20. [Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].
Frank-Raue K; Heimbach C; Rondot S; Usadel KH; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
Dtsch Med Wochenschr; 2003 Sep; 128(39):1998-2002. PubMed ID: 14508694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
